Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
PaperCitations, authors & open-access status
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 475 citations, 2020 year and bronze oa status.
475
Citations
2020
Year
bronze
OA Status